Scott Webster - Projects - University of Edinburgh Research Explorer

View Scopus Profile

Phone0131 242 6738
EmailScott.Webstered.acuk

20 results

Finished

Personalized Treatment For Pleural Mesothelioma Patients By Taming The Hippo
Hansen, C., Carragher, N., Carragher, N. & Webster, S.
Lifearc
1/12/21 → 31/10/23
Project: Research
Targeting the long non-coding RNA SMILR using small interfering RNA for therapeutic intervention in vein graft failure
Baker, A., Mahmoud, A. & Webster, S.
UK-based charities
1/05/21 → 30/06/23
Project: Research
Generating small molecule inhibitors of ENPP1 for cancer treatment
Webster, S.
MRC
1/02/21 → 30/06/22
Project: Research
Targeting S100A8/A9 as a new anti-inflammatory treatment for Cystic Fibrosis
Webster, S.
MRC
1/09/20 → 23/11/21
Project: Research
Targeting S100A8/A9 as a new anti-inflammatory treatment for Cystic Fibrosis
Hay, D., Gray, R. & Webster, S.
MRC
1/09/20 → 23/11/21
Project: Research
Accelerating translation from medical research in Edinburgh
Webster, S., Ffrench-Constant, C. & McBride, A.
MRC
31/03/20 → 31/03/23
Project: Research
CYPNASH: Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis
Webster, S.
EU government bodies
1/10/19 → 31/12/21
Project: Research
Dpac Extension
Webster, S.
UK industry, commerce and public corporations
22/08/19 → 31/12/19
Project: Research
Identifying inhibitors of ENPP6 for treatment of obesity and cardiometabolic disease
Webster, S. & Morton, N.
MRC
1/07/19 → 31/12/20
Project: Research
Research Excellence Award Number 3
Newby, D., Bailey, M., Baker, A., Dweck, M., Mills, N., Morton, N., Pearson, E., Reynolds, R., Semple, R. & Webster, S.
UK-based charities
1/04/19 → 31/03/24
Project: Research
Hit-to-lead optimisation of novel ENPP6 inhibitors: a new therapeutic target for cardiometabolic disease
Webster, S. & Morton, N.
MRC
1/09/18 → 30/09/19
Project: Research
Institutional Translational Partnership Award: University of Edinburgh
Seckl, J., Adams, S., Barlow, P., Brunton, V., Carragher, N., Crompton, C., Doughty Shenton, D., Dransfield, I., Fletcher-Watson, S., French, C., Gorjanc, G., Hutchison, A., Jepson, R., Jones, J., Kitamura, T., Kunath, T., Ly, T., McDougal, E., Rhodes, S., Robertson, N., Rome, P., Selli Karakaya, C., Stagg, H., Stanfield, A., Sudlow, C., Vendrell Escobar, M., Wallace, E., Wang, B., Webster, S., Williams, S., Wu, H. & Zuntz, J.
UK-based charities
15/06/18 → 18/02/22
Project: Research
Profiling of novel Autotaxin (ATX) inhibitors in phenotypic models of organ fibrosis
Webster, S.
MRC
1/06/18 → 31/08/19
Project: Research
Building Edinburgh's Drug Discovery Ecosystem (P2D 4)
Webster, S.
MRC
31/03/18 → 31/07/21
Project: Research
Developing a small molecule screening cascade for ectonucleotide pyrophosphatase (ENPP6): an early stage therapeutic target for cardiometabolic disease
Webster, S. & Morton, N.
MRC
1/07/17 → 31/12/17
Project: Research
Mass Spectrometry imaging in translational endocrine research
Andrew, R., Lang, C., Newby, D., Saunders, P., Walker, B. & Webster, S.
UK-based charities
1/07/17 → 31/12/22
Project: Research
Identification of selective and potent inhibitors of the Semaphorin 3A Receptor Neuropilin-1 interaction on oligodendrocyte precursor cells to promote remyelination in Multiple Sclerosis
Webster, S.
Non-EU industry, commerce and public corporations
1/03/15 → 28/02/17
Project: Research
Relaxin DPAc Collaboration
Webster, S.
UK industry, commerce and public corporations
1/02/14 → 27/07/15
Project: Research
KYNERNINE PATHWAY INHIBITION IN MULTIPLE ORGAN FAILURE
Webster, S. & Doherty, C.
MRC
1/07/12 → 31/07/13
Project: Research
THE ROLE OF KMO INHIBITORS
Webster, S. & Mole, D.
UK industry, commerce and public corporations
1/11/11 → 31/12/17
Project: Research